Decreased survival after conversion to serum HER-2/neu positive.

被引：0
|
作者：
Lipton, A
Leitzel, K
Ali, SM
Demers, L
Harvey, HA
Chaudri-Ross, H
Lang, R
Hackl, W
Hamer, P
Carney, W
机构：
[1] W Penn State Hershey Med Ctr, Hershey, PA USA
[2] Lebanon VA Med Ctr, Lebanon, PA USA
[3] Novartis Pharma AG, Basel, Switzerland
[4] Oncogene Sci Bayer Diagnost, Cambridge, MA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
508
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [31] Correlation of serum HER-2/neu extracellular domain levels in metastatic breast cancer with the expression of HER-2/neu determined by immunohistochemistry in primary tumors.
    Witzel, I
    Thomssen, C
    Pantel, K
    Neumann, R
    Carney, W
    Loening, T
    Jaenicke, F
    Mueller, V
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S143 - S143
  • [32] Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
    Disis, ML
    Gooley, TA
    Rinn, K
    Davis, D
    Piepkorn, M
    Cheever, MA
    Knutson, KL
    Schiffman, K
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) : 2624 - 2632
  • [33] Sebaceous carcinomas of the eyelid are frequently EGFR positive and HER-2/neu negative
    Cameron, S. E. H.
    Cameron, J. D.
    Manivel, J. C.
    Forster, C.
    Pambuccian, S. E.
    MODERN PATHOLOGY, 2007, 20 : 302A - 303A
  • [34] Sebaceous carcinomas of the eyelid are frequently EGFR positive and HER-2/neu negative
    Cameron, S. E. H.
    Cameron, J. D.
    Manivel, J. C.
    Forster, C.
    Pambuccian, S. E.
    LABORATORY INVESTIGATION, 2007, 87 : 302A - 303A
  • [35] Multiple Subtypes of HER-2/Neu-Positive Metastatic Breast Cancer
    Lipton, A.
    Leitzel, K.
    Koestler, W.
    Fuchs, E-M
    Singer, C. F.
    Ali, S. M.
    Huang, W.
    Sperinde, J.
    Goodman, L.
    Jin, X.
    Barerjee, J.
    Weston, J.
    Mukherjee, A.
    Larson, J.
    Weidler, J.
    Paquet, A.
    Williams, S.
    Winslow, J.
    Parry, G.
    Bates, M.
    CANCER RESEARCH, 2009, 69 (24) : 601S - 602S
  • [36] Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    ONCOLOGIST, 2006, 11 (08): : 857 - 867
  • [37] HER-2/neu Gene Amplification in Esophageal Adenocarcinoma and Its Influence on Survival
    Thompson, Sarah K.
    Sullivan, Thomas R.
    Davies, Ruth
    Ruszkiewicz, Andrew R.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (07) : 2010 - 2017
  • [38] HER-2/neu Gene Amplification in Esophageal Adenocarcinoma and Its Influence on Survival
    Sarah K. Thompson
    Thomas R. Sullivan
    Ruth Davies
    Andrew R. Ruszkiewicz
    Annals of Surgical Oncology, 2011, 18 : 2010 - 2017
  • [39] HER-2/neu overexpression and its effect on survival in solid tumors.
    Tendulkar, K
    Ganti, AK
    Koka, V
    Koch, M
    Potti, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 849S - 849S
  • [40] HER-2/neu expression in pancreatic adenocarcinoma: Relation to tumor differentiation and survival
    Dugan, MC
    Dergham, ST
    Kucway, R
    Singh, K
    Biernat, L
    Du, W
    Vaitkevicius, VK
    Crissman, JD
    Sarkar, FH
    PANCREAS, 1997, 14 (03) : 229 - 236
12345